How accurate are doctors, nurses and medical students at predicting life expectancy?

European Journal of Internal Medicine

Volumn 20, Issue 6, 2009, Pages 640-644

  Clarke, Michael G ^a   Ewings, P ^b   Hanna, T ^c   Dunn, L ^d   Girling, T ^d   Widdison, A L ^c  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

^c ROYAL CORNWALL HOSPITAL   (United Kingdom)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Actuarial analysis; Comorbidity; Decision making; Life expectancy

Indexed keywords

ACCURACY; ARTICLE; COMORBIDITY; EVIDENCE BASED MEDICINE; INSURANCE; LIFE EXPECTANCY; MEASUREMENT ERROR; MEDICAL EDUCATION; MEDICAL STUDENT; NURSE; PHYSICIAN; RELIABILITY;

FORECASTING; HUMANS; LIFE EXPECTANCY; NURSES; OBSERVER VARIATION; PHYSICIANS; REPRODUCIBILITY OF RESULTS; STUDENTS, MEDICAL;

EID: 70349289089     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.06.009     Document Type: Article

References (29)

1. Wilson J., Graham J., and MacDonagh R. Patient life expectancy: a vital element in planning treatment?. BJU Int 93 (2004) 461-463
2. Royal College of Radiologists' Clinical Oncology Information Network. British Association of Urological Surgeons: guidelines on the management of prostate cancer. BJU Int 84 (1999) 987-1014
3. Walz J., Gallina A., Perrotte P., Jeldres C., Trinh Q.D., Hutterer G.C., et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 100 (2007) 1254-1258
4. Wilson J.R.M., Clarke M.G., Ewings P., Graham J.D., and MacDonagh R. The assessment of patient life-expectancy: how accurate are urologists and oncologists?. BJU Int 95 (2005) 794-798
5. Vigano A., Dorgan M., Bruera E., and Suarez-Almazor M.E. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 86 (2000) 170-176
6. Glare P., Virik K., Jones M., Hudson M., Eychmuller S., Simes J., et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327 (2003) 195
7. Stone P.C., and Lund S. Predicting prognosis in patients with advanced cancer. Ann Oncol 18 (2007) 971-976
8. Tanneberger S., Malavasi I., Mariano P., Pannuti F., and Strocchi E. Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients. Ann Oncol 13 (2002) 1320-1322
9. Christakis N.A., and Lamont E.B. Extent and determinants of error in physicians' prognoses in terminally ill patients. West J Med 172 (2000) 310-313
10. Krahn M.D., Bremner K.E., Asaria J., Alibhai S.M.H., Nam R., Tomlinson G., et al. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localised prostate cancer. Urology 60 (2002) 258-263
11. Alibhai S.M.H., Krahn M.D., Cohen M.M., Fleshner N.E., Tomlinson G.A., and Naglie G. Is there age bias in the treatment of localized prostate cancer?. Cancer 100 (2004) 72-81
12. Koch M.O., Miller D.A., Butler R., Lebos L., Collings D., and Smith Jr. J.A. Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology 51 (1998) 197-202
13. Audisio R.A., Ramesh H., Longo W.E., Zbar A.P., and Pope D. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 10 (2005) 262-268
14. Kirwan J.R. Clinical judgement in rheumatoid arthritis. I. Rheumatologists' opinions and the development of paper patients. Ann Rheum Dis 42 (1983) 644-647
15. Brackenridge R.D.C., Croxson R.S., and Mackenzie R. Medical selection of life risks. 5th ed. (2006), Palgrave Macmillan
16. Government Actuary's Department. http://www.gad.gov.uk/Demography_Data/Life_Tables/Interim_life_tables.asp.
17. Maltoni M., Caraceni A., Brunelli C., Broeckaert B., Christakis N., Eychmueller S., et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the steering committee of the European Association for Palliative Care. J Clin Oncol 23 (2005) 6240-6248
18. Llobera J., Esteva M., Rifa J., Benito E., Terrasa J., Rojas C., et al. Terminal cancer: duration and prediction of survival time. Eur J Cancer 36 (2000) 2036-2043
19. Singh R., and O'Brien T.S. Comorbidity assessment in localised prostate cancer: a review of currently available techniques. Eur Urol 46 (2004) 28-41
20. Morita T., Tsunoda J., Inoue S., and Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Supp Care Cancer 7 (1999) 128-133
21. Pirovano M., Maltoni M., Nanni O., Marinari M., Indelli M., Zaninetta G., et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients - Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17 (1999) 231-239
22. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
23. Greenfield S., Aronow H.U., Elashoff R.M., and Watanabe D. Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA 260 (1988) 2253-2255
24. New Classification of Physical Status. American Society of Anesthesiologists. Anesthesiology 24 (1963) 111
25. Lawton M.P., and Brody E.M. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
26. Brink T.L., Yesavage J.A., Lum O., Hursema P.H., Adey M., and Rose T.L. Screening test for geriatric depression. Clin Gerontol 1 (1982) 37-44
27. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden T.E., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
28. Clarke M.G., Kennedy K.P., and MacDonagh R.P. Development of a clinical prediction model to calculate patient life expectancy - the measure of actuarial life expectancy (MALE). Med Decis Making 29 2 (2009 Mar-Apr) 239-246
29. Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 5 (2004) 101-106